Health Catalyst (HCAT) grants 80,691 RSUs to director Julie Larson-Green

Rhea-AI Filing Summary

Larson-Green Julie reported acquisition or exercise transactions in this Form 4 filing.

Julie Larson-Green, a director of Health Catalyst, Inc., received an equity award of 80,691 restricted stock units (RSUs) of common stock on July 16, 2026. Each RSU represents one share and will fully vest on the earlier of the one-year anniversary of the grant date or the next annual meeting of stockholders. Following this award, she directly holds 175,335 shares of common stock.

Insider Trade Summary

Net Buyer: 80,691 shares

Net Buy 1 txn

Insider Larson-Green Julie

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	80,691	$0.00	$0.00

Holdings After Transaction: Common Stock — 175,335 shares (Direct)

Footnotes (1)

1. F1. Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will fully vest on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the next Annual Meeting of the Issuer's Stockholders.

Key Figures

RSUs granted: 80,691 shares Grant price: $0.0000 per share Holdings after grant: 175,335 shares +1 more

4 metrics

RSUs granted 80,691 shares Restricted stock units of common stock granted on July 16, 2026

Grant price $0.0000 per share Reported price per share for the RSU award

Holdings after grant 175,335 shares Total direct common stock reported following the RSU award

Vesting period 1 year RSUs fully vest on the one-year anniversary or earlier at the next annual meeting

Key Terms

restricted stock units, 2019 Stock Option and Incentive Plan, Annual Meeting of the Issuer's Stockholders

3 terms

restricted stock units financial

"Represents an award of restricted stock units (RSUs) granted pursuant to the 2019 Plan."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

2019 Stock Option and Incentive Plan financial

"RSUs granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan."

Annual Meeting of the Issuer's Stockholders regulatory

"RSUs will fully vest on the earlier of one year or the next Annual Meeting of the Issuer's Stockholders."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/20/2026 - 05:19 PM Accepted by SEC EDGAR 07/20/2026 - 05:19 PM Learn about SEC filing dates

FAQ

What insider transaction did Health Catalyst (HCAT) report for Julie Larson-Green?

Health Catalyst reported that director Julie Larson-Green received an equity award of 80,691 RSUs of common stock on July 16, 2026. After this grant, her reported direct holdings total 175,335 shares of Health Catalyst common stock.

How many RSUs were granted to Julie Larson-Green in the latest HCAT Form 4?

The Form 4 shows a grant of 80,691 restricted stock units (RSUs) to director Julie Larson-Green. Each RSU represents a contingent right to receive one share of Health Catalyst common stock, subject to the plan terms and vesting conditions.

What is the vesting schedule for Julie Larson-Green’s 80,691 HCAT RSUs?

The 80,691 RSUs will fully vest on the earlier of one year from the grant date or the date of the next Annual Meeting of the Issuer's Stockholders, subject to the terms of Health Catalyst’s 2019 Stock Option and Incentive Plan.

What are Julie Larson-Green’s total HCAT share holdings after this RSU award?

After the reported RSU award, Julie Larson-Green’s total direct holdings are 175,335 shares of Health Catalyst common stock. This figure reflects the total common stock position reported following the 80,691 RSU grant.

Was there a purchase price for the 80,691 HCAT RSUs granted to Julie Larson-Green?

The RSU award is reported with a per-share price of $0.0000, reflecting a grant or award of equity compensation rather than an open-market purchase. The RSUs convert into common shares upon vesting under the plan terms.

Under which plan were Julie Larson-Green’s HCAT RSUs granted?

The 80,691 RSUs granted to Julie Larson-Green were issued under Health Catalyst’s 2019 Stock Option and Incentive Plan. This plan governs the terms of the RSU award, including vesting and the right to receive common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Larson-Green Julie

(Last) (First) (Middle)

C/O HEALTH CATALYST, INC.

10897 SOUTH RIVER FRONT PARKWAY, #300

(Street)

SOUTH JORDAN UTAH 84095

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Health Catalyst, Inc. [ HCAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/16/2026		A		80,691(1)	A	$0.00	175,335	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will fully vest on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the next Annual Meeting of the Issuer's Stockholders.

Remarks:

	/s/Benjamin Landry, as Attorney-in-Fact	07/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)